Cargando…
Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®
BACKGROUND: By definition, a generic product is considered interchangeable with the innovator brand product. Controversy exists about interchangeability, and attention is predominantly directed to contaminants. In particular for chronic, degenerative conditions such as in Parkinson’s disease (PD) ge...
Autores principales: | Gasser, Urs E, Fischer, Anton, Timmermans, Jan P, Arnet, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648491/ https://www.ncbi.nlm.nih.gov/pubmed/23617953 http://dx.doi.org/10.1186/2050-6511-14-24 |
Ejemplares similares
-
Controlled-release levodopa methyl ester/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats
por: Yang, Xinxin, et al.
Publicado: (2012) -
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off
por: Kuoppamäki, Mikko, et al.
Publicado: (2015) -
Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in rats
por: Alirezaei, Masoud
Publicado: (2015) -
Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats
por: Yang, Xinxin, et al.
Publicado: (2012) -
Efficacy and motor complications of original and generic levodopa in Parkinson’s disease treatment
por: Kasemsap, Narongrit, et al.
Publicado: (2016)